Press "Enter" to skip to content

New patent for Dexcel Pharma drug OMEPRAZOLE

1
Copyright © DrugPatentWatch. Originally published at New patent for Dexcel Pharma drug OMEPRAZOLE

Annual Drug Patent Expirations for OMEPRAZOLE
Annual Drug Patent Expirations for OMEPRAZOLE

Omeprazole is a drug marketed by Actavis Labs Fl Inc, Apotex, Aurobindo Pharma Ltd, Breckenridge, Dr Reddys Labs Ltd, Glenmark Generics, Hetero Labs Ltd Iii, Impax Labs, Lannett Co Inc, Lupin Ltd, Mylan, Sandoz, Teva Pharms Usa, Zydus Pharms Usa Inc, Dexcel Pharma, Dr Reddys, Sun Pharm, Cumberland Pharms, Ajanta Pharma Ltd, Aurolife Pharma Llc, Guardian Drug, Par Pharm, Perrigo R And D, Sciegen Pharms Inc, Unicorn, Zydus Pharms, Spil, and P And L and, and is included in forty-three NDAs. It is available from eigthy-five suppliers. There are two patents protecting this drug and one Paragraph IV challenge.

Drug patent litigation for OMEPRAZOLE.

This drug has twelve patent family members in eight countries.

The generic ingredient in OMEPRAZOLE is omeprazole magnesium. Eigthy-five suppliers are listed for this compound. There is one tentative approval for this compound. Additional details are available on the omeprazole magnesium profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Dexcel Pharma drug OMEPRAZOLE

Comments are closed.

Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!